Aptamer Targets Triple-Negative Breast Cancer through Specific Binding to Surface CD49c

Aptamer Targets Triple-Negative Breast Cancer through Specific Binding to Surface CD49c

Although targeted cancer therapy can induce higher therapeutic efficacy and cause fewer side effects in patients, the lack of targetable biomarkers on triple-negative breast cancer (TNBC) cells limits the development of targeted therapies by antibody technology. Therefore, we investigated an alterna...

Full description

Bibliographic Details
Main Authors:	Quanyuan Wan, Zihua Zeng, Jianjun Qi, Yingxin Zhao, Xiaohui Liu, Zhenghu Chen, Haijun Zhou, Youli Zu
Format:	Article
Language:	English
Published:	MDPI AG 2022-03-01
Series:	Cancers
Subjects:	aptamer ligand biomarker identification integrin α3/CD49c triple-negative breast cancer (TNBC) targeted cancer therapy
Online Access:	https://www.mdpi.com/2072-6694/14/6/1570

Similar Items

Tumor-initiating CD49f cells are a hallmark of chemoresistant triple negative breast cancer
by: Jorge Gomez-Miragaya, et al.
Published: (2017-07-01)

Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population
by: Jorge Gómez-Miragaya, et al.
Published: (2017-05-01)

Aptamer Cocktail to Detect Multiple Species of Mycoplasma in Cell Culture
by: Quanyuan Wan, et al.
Published: (2020-05-01)

Metastatic Triple Negative Breast Cancer: The New Era of Thinking
by: Mohammed Amrallah A., et al.
Published: (2021-05-01)

Characterizing the Inflammatory Profile of Neutrophil-Rich Triple-Negative Breast Cancer
by: Fatma Al Qutami, et al.
Published: (2024-02-01)

Targeting triple-negative breast cancer cells with a β1-integrin binding aptamer
by: Karlis Pleiko, et al.
Published: (2023-09-01)

The Relevance of the SH2 Domain for c-Src Functionality in Triple-Negative Breast Cancer Cells
by: Víctor Mayoral-Varo, et al.
Published: (2021-01-01)

Formation and phenotypic characterization of CD49a, CD49b and CD103 expressing CD8 T cell populations in human metastatic melanoma
by: Marit M. Melssen, et al.
Published: (2018-10-01)

Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive
by: Dey Nandini, et al.
Published: (2021-05-01)

Altered Adipokine Expression in Tumor Microenvironment Promotes Development of Triple Negative Breast Cancer
by: Efthymia Papakonstantinou, et al.
Published: (2022-08-01)

Aptamer-Based Strategies to Boost Immunotherapy in TNBC
by: Lisa Agnello, et al.
Published: (2023-03-01)

Precision Medicine and Triple-Negative Breast Cancer: Current Landscape and Future Directions
by: Fokhrul Hossain, et al.
Published: (2021-07-01)

Optimization of Short RNA Aptamers for TNBC Cell Targeting
by: Simona Camorani, et al.
Published: (2022-03-01)

Ferroptosis induction via targeting metabolic alterations in triple-negative breast cancer
by: Yaru Wang, et al.
Published: (2023-12-01)

Aptamers with Self-Loading Drug Payload and pH-Controlled Drug Release for Targeted Chemotherapy
by: Zihua Zeng, et al.
Published: (2021-08-01)

Association of CD206 Protein Expression with Immune Infiltration and Prognosis in Patients with Triple-Negative Breast Cancer
by: Angélique Bobrie, et al.
Published: (2022-10-01)

Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC)
by: Aiswarya Chaudhuri, et al.
Published: (2022-04-01)

Editorial: Targeting triple negative breast cancer by natural compounds
by: Shashank Kumar, et al.
Published: (2023-03-01)

Expression of Circular RNA ciRS-7 and Its Effect on Invasion and Migration of Triple-negative Breast Cancer Cells
by: MENG Lingjiao, et al.
Published: (2019-03-01)

New Achievements for the Treatment of Triple-Negative Breast Cancer
by: Alessia Catalano, et al.
Published: (2022-05-01)

Androgen Receptor Expression in Triple-Negative Breast Cancer
by: Samane Jam, et al.
Published: (2019-05-01)

9S1R nullomer peptide induces mitochondrial pathology, metabolic suppression, and enhanced immune cell infiltration, in triple-negative breast cancer mouse model
by: Nilufar Ali, et al.
Published: (2024-01-01)

Tumor immune microenvironment and genomic evolution in a patient with metastatic triple negative breast cancer and a complete response to atezolizumab
by: Luciana Molinero, et al.
Published: (2019-10-01)

Cancer-Specific Outcomes in the Elderly with Triple-Negative Breast Cancer: A Systematic Review
by: Jenny Yoon, et al.
Published: (2021-06-01)

Regulation and Functions of α6-Integrin (CD49f) in Cancer Biology
by: Rahele Khademi, et al.
Published: (2023-07-01)

Benzo[<i>f</i>]indole-4,9-dione Derivatives Effectively Inhibit the Growth of Triple-Negative Breast Cancer
by: Fabiana Sélos Guerra, et al.
Published: (2021-07-01)

Selective Photo-Assisted Eradication of Triple-Negative Breast Cancer Cells through Aptamer Decoration of Doped Conjugated Polymer Nanoparticles
by: Luis Exequiel Ibarra, et al.
Published: (2022-03-01)

Identification of hub genes and diagnostic efficacy for triple-negative breast cancer through WGCNA and Mendelian randomization
by: Yilong Lin, et al.
Published: (2024-04-01)

Moment of truth-adding carboplatin to neoadjuvant/adjuvant chemotherapy in triple negative breast cancer improves overall survival: An individual participant data and trial-level Meta-analysis
by: Neha Pathak, et al.
Published: (2022-08-01)

Signaling Pathways and Natural Compounds in Triple-Negative Breast Cancer Cell Line
by: Citra Dewi, et al.
Published: (2022-06-01)

Efficacy and Safety of Capecitabine for Triple-Negative Breast Cancer: A Meta-Analysis
by: Xueqiong Xun, et al.
Published: (2022-07-01)

Association of FOSL1 copy number alteration and triple negative breast tumors
by: Leandro Tamião Rodrigues Serino, et al.
Published: (2019-02-01)

Antisense Oligonucleotide-Based Therapeutic against Menin for Triple-Negative Breast Cancer Treatment
by: Dang Tan Nguyen, et al.
Published: (2021-07-01)

Synergistic effects of combined cisplatin and Clinacanthus nutans extract on triple negative breast cancer cells
by: Nur Fitriyani Afiqah Binti Abu Bakar, MSc, et al.
Published: (2023-12-01)

Molecular Investigation on a Triple Negative Breast Cancer Xenograft Model Exposed to Proton Beams
by: Francesco P. Cammarata, et al.
Published: (2020-09-01)

Prognostic Value of Ki-67 in Patients With Resected Triple-Negative Breast Cancer: A Meta-Analysis
by: Qiang Wu, et al.
Published: (2019-10-01)

Prognostic Impact of CD38- and IgκC-Positive Tumor-Infiltrating Plasma Cells in Triple-Negative Breast Cancer
by: Anne-Sophie Heimes, et al.
Published: (2023-10-01)

Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance
by: David P. Hill, et al.
Published: (2019-11-01)

FUNDC2, a mitochondrial outer membrane protein, mediates triple-negative breast cancer progression via the AKT/GSK3β/GLI1 pathway
by: Yin Liyang, et al.
Published: (2023-09-01)

Epidemiology, Pattern of Recurrence and Survival in Triple-negative Breast Cancer
by: Dharmendra Singh, et al.
Published: (2020-06-01)